181 related articles for article (PubMed ID: 20816581)
1. Heritability of hematologic malignancies: from pedigrees to genomics.
Churpek JE; Onel K
Hematol Oncol Clin North Am; 2010 Oct; 24(5):939-72. PubMed ID: 20816581
[TBL] [Abstract][Full Text] [Related]
2. Frequency of hematologic and solid malignancies in the family history of 50 patients with acute myeloid leukemia - a single center analysis.
Sandner AS; Weggel R; Mehraein Y; Schneider S; Hiddemann W; Spiekermann K
PLoS One; 2019; 14(4):e0215453. PubMed ID: 30998723
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract][Full Text] [Related]
4. Discussing and managing hematologic germ line variants.
Kohlmann W; Schiffman JD
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):309-315. PubMed ID: 27913496
[TBL] [Abstract][Full Text] [Related]
5. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Predisposition to Hematopoietic Neoplasms: When Bloodline Matters for Blood Cancers.
Mangaonkar AA; Patnaik MM
Mayo Clin Proc; 2020 Jul; 95(7):1482-1498. PubMed ID: 32571604
[TBL] [Abstract][Full Text] [Related]
7. Leveraging cancer genome information in hematologic malignancies.
Rampal R; Levine RL
J Clin Oncol; 2013 May; 31(15):1885-92. PubMed ID: 23589554
[TBL] [Abstract][Full Text] [Related]
8. Predisposition to pediatric and hematologic cancers: a moving target.
Malkin D; Nichols KE; Zelley K; Schiffman JD
Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
[TBL] [Abstract][Full Text] [Related]
9. Genomic testing in myeloid malignancy.
Docking TR; Karsan A
Int J Lab Hematol; 2019 May; 41 Suppl 1():117-125. PubMed ID: 31069982
[TBL] [Abstract][Full Text] [Related]
10. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
Trottier AM; Godley LA
Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
[TBL] [Abstract][Full Text] [Related]
11. Hereditary myeloid malignancies.
Rafei H; DiNardo CD
Best Pract Res Clin Haematol; 2019 Jun; 32(2):163-176. PubMed ID: 31203998
[TBL] [Abstract][Full Text] [Related]
12. Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes.
Ansar S; Malcolmson J; Farncombe KM; Yee K; Kim RH; Sibai H
Genet Med; 2022 Nov; 24(11):2367-2379. PubMed ID: 36112138
[TBL] [Abstract][Full Text] [Related]
13. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
14. Genitourinary cancer predisposition syndromes.
Gallagher DJ; Feifer A; Coleman JA
Hematol Oncol Clin North Am; 2010 Oct; 24(5):861-83. PubMed ID: 20816578
[TBL] [Abstract][Full Text] [Related]
15. Discussing and managing hematologic germ line variants.
Kohlmann W; Schiffman JD
Blood; 2016 Nov; 128(21):2497-2503. PubMed ID: 27881370
[TBL] [Abstract][Full Text] [Related]
16. [Genetics of hereditary hematological malignancies].
Takagi M
Rinsho Ketsueki; 2015 Oct; 56(10):1969-77. PubMed ID: 26458435
[TBL] [Abstract][Full Text] [Related]
17. Germline Genetic Predisposition to Hematologic Malignancy.
Furutani E; Shimamura A
J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
[TBL] [Abstract][Full Text] [Related]
18. Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.
Stubbins RJ; Korotev S; Godley LA
Curr Hematol Malig Rep; 2022 Aug; 17(4):94-104. PubMed ID: 35674998
[TBL] [Abstract][Full Text] [Related]
19. Myeloid Malignancies: Recognizing the Risk of Germline Predisposition and Supporting Patients and Families.
Friend P; Mahon SM
Clin J Oncol Nurs; 2021 Oct; 25(5):519-522. PubMed ID: 34533515
[TBL] [Abstract][Full Text] [Related]
20. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
